Special Issue "Chitosan-Based Nanomaterials for Biomedical Applications"
Deadline for manuscript submissions: 28 February 2019
Being the second most abundant natural polymer on Earth, chitosan possesses many unique chemical, structural and biological properties that make it attractive for numerous biomedical applications. Chitosan can be easily fabricated into different nanomaterials or nanocomposites, such as nanofibers, nanoparticles, gels, micelles and liposomes, to suit different needs. In addition, numerous approaches developed for chitosan have also overcome limitations in biomedical fields by using chitosan derivatives, composites or nanocomposites. Although numerous papers have discussed the application of chitosan nanomaterials in biomedical fields, they are found dispersed in different scientific journals. Consequently, this Special Issue aims to provide a broad coverage of recent research progress or up-to-date reviews addressing various aspects in this field. With this Special Issue, we aim to provide the readers with the opportunity to learn about different facets of biomedical research using chitosan-based nanomaterials. For the authors, this Special Issue will provide a unique opportunity to make their research results more visible to the scientific community. This Special Issue is seeking contributions from researchers to discuss all application aspects of chitosan nanomaterials in tissue engineering, regenerative medicine, drug delivery, wound healing and diagnostics. Critical reviews by experts in these fields are also welcomed.Prof. Jyh-Ping Chen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Tissue Engineering
- Regenerative Medicine
- Drug Delivery
- Wound Healing
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Chitosan-Based Nanomaterials for Drug Delivery
Author: Chao Cai
Affiliation: Key Lab of Marine Drugs, Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Drug Building A303, No.5 Yushan Road, Qingdao, 266003 China
Abstract: The rapid development of nanomaterials has provided wonderful opportunities for the creation of new pharmaceutical preparations. As a drug carrier, nanomaterials integrate multiple functions into itself, including target delivery, environmental response triggered, biocompatibility and so on. Chitosan (CS), a natural biological polysaccharides, is a well-known promising drug delivery vector for therapeutics and diagnostics, owing to its biocompatibility, biodegradable, low toxicity and structure-modifiable. CS and its derivatives have been developed into various pharmaceutical applications such as colon target drug delivery, mucosal delivery, cancer therapy and so on. This review article discusses different forms of nanomaterials for drug delivery by using various approaches for the preparation of chitosan derivatives or nanocomposites.